Black Rock Inc. Regencell Bioscience Holdings LTD Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Black Rock Inc. holds 238 shares of RGC stock, worth $3,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
238
Previous 238
-0.0%
Holding current value
$3,253
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGC
# of Institutions
8Shares Held
19.8KCall Options Held
0Put Options Held
0-
Greenfield Savings Bank11KShares$150,3700.09% of portfolio
-
Geode Capital Management, LLC Boston, MA6.82KShares$93,1740.0% of portfolio
-
Royal Bank Of Canada Toronto, A6948Shares$12,9590.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY698Shares$9,5410.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA50Shares$6830.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $178M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...